Home|Journals|Articles by Year|Audio Abstracts
 

Original Article



Levels of Plasma C-reactive protein, Albumin and Pre-Albumin in Nigerian COVID-19 Patients

Ganiyu Olatunbosun Arinola, Fabian Victory Edem, Temitope Oluwagbenga Alonge.




Abstract
Cited by 2 Articles

Aim: COVID-19 is a new viral, rapidly infectious and inflammatory disease, with no treatment currently.However, no study reported combination of high sensitive C-reactive protein (a marker of inflammation), albumin and prealbumin (markers of nutritional status)in the prognosis of COVID-19 among Nigerian COVID-19 patients. We assessed plasma levels of hsCRP, albumin, prealbumin, hsCRP-albumin ratio and hsCRP-prealbumin ratio in newly admitted COVID-19 patients and COVID-19 patients at discharge.
Material and Methods: Albumin, pre-albumin and C-RP levels were determined in the plasma of confirmed cases of COVID-19 recruited form one Infectious Diseases Center, Ibadan, Nigeria using ELISA. hsCRP-albumin ratio and hsCRP-prealbumin ratio were calculated. All these parameters were compared in both groups of patients and controls.
Results: hsC-RP level was significantly higher in newly admitted COVID-19 patients compared with discharged COVID-19 patients or COVID-19 free control (p0.05).The mean values of plasma hsC-RP, albumin and prealbumin in most COVID-19 patients (89%, 100% and 91% respectively) were within normal reference ranges. hsC-RP were significantly increased in newly admitted COVID-19 patients who were females, above 40 years of age and stayed above 10 days of hospital admission (p

Key words: COVID-19; inflammatory factors; nutrititional indicators; prognosis






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.